Ignite Creation Date:
2024-05-06 @ 1:12 AM
Last Modification Date:
2024-10-26 @ 11:00 AM
Study NCT ID:
NCT01752920
Status:
COMPLETED
Last Update Posted:
2023-06-05
First Post:
2012-12-14
Brief Title:
Phase 12 Study of Derazantinib ARQ 087 in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations
Sponsor:
Basilea Pharmaceutica
Organization:
Basilea Pharmaceutica
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12-10
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-28
Completion Date Type:
ACTUAL
First Submit Date:
2012-12-14
First Submit QC Date:
December 17 2012
Study First Post Date:
2012-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-10-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2019-10-18
Disp First Submit QC Date:
October 18 2019
Disp First Post Date:
2019-10-31
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-05-09
Last Update Post Date:
2023-06-05
Last Update Post Date Type:
ACTUAL